MARC record from Internet Archive

LEADER: 04752cam 2200817 a 4500
001 ocm27854548
003 OCoLC
005 20200507025127.0
008 930311s1993 enka b 001 0 eng
010 $a 93017041
040 $aDNLM/DLC$beng$cDLC$dNLM$dUKM$dTMV$dOCLCQ$dBAKER$dNLGGC$dBTCTA$dYDXCP$dZWZ$dDEBBG$dOCLCQ$dBDX$dGBVCP$dOCLCO$dOCLCF$dOCLCQ$dDHA$dOCLCQ$dUWO$dOCLCQ$dOCLCO$dBUF$dOCLCO$dOCLCA$dL2U$dOCLCA
015 $aGB9403470$2bnb
016 7 $a9305195$2DNLM
016 7 $a052-14129$2Uk
019 $a29702622$a30547236
020 $a052141296X$q(hc)
020 $a9780521412964$q(hc)
035 $a(OCoLC)27854548$z(OCoLC)29702622$z(OCoLC)30547236
050 00 $aRM301.3.G45$bP75 1993
060 00 $aQV 38$bP945g 1993
082 00 $a615/.7$220
084 $a44.38$2bcl
084 $a44.48$2bcl
084 $aVS 5380$2rvk
084 $aXI 2150$2rvk
100 1 $aPrice Evans, David A.
245 10 $aGenetic factors in drug therapy :$bclinical and molecular pharmacogenetics /$cDavid A. Price Evans.
260 $aCambridge [England] ;$aNew York :$bCambridge University Press,$c1993.
300 $axxiii, 657 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references (page 627) and index.
505 0 $aArrangement of the information in this volume -- General introduction -- Classification of pharmacogenetic phenomena -- Cytochrome P450 based phenomena -- Cytochromes P450: general features -- Arylhydrocarbon hydroxylase (cytochrome P450 1A1 and 1A2 -- Mephenytoin hydroxylation polymorphism (cytochrome P450 2C18) -- Debrisoquine/sparteine polymorphism (cytochrome P450 2D6) -- Cytochrome P450 3A subfamily -- Tolbutamide -- Phenytoin -- Some other drugs of special interest -- Cytochrome P450 reductase -- Cholinesterase -- Alcohol and alcoholism -- N-acetyltransferase -- Miscellaneous phase reactions showing genetic variability in drug metabolism -- Glucosidation of amobarbital -- Glucuronosyltransferases -- Glutathione-S-transferase -- Methylation reactions -- Paraxonase -- Sulphotransferases -- Sulphoxidation deficiency -- Halothane hepatitis and other topics -- Glucose-6-phosphate dehydrogenase deficiency -- Hepatic porphyrias -- Malignant hyperthermia -- Miscellaneous systems showing genetic variability in response to drugs.
505 0 $a(cont) Chlorpropamide: alcohol flushing -- Glucocorticosteroids and intraocular pressure -- Unstable haemoglobins -- Human lymphocyte antigens and adverse reactions to drugs -- Polymorphism for tasting phenylthiocarbamide (PTC syn phenylthiourea) -- Hereditary anticoagulant resistance -- NADH-cytochrome [beta]5 reductase -- Catalase -- Antibiotic-induced deafness, chloramphenicol toxicity and other topics -- Polygenic effects in pharmacogenetics -- Common themes -- Computing the degree of dominance -- Exponential decay -- Disentanglement of overlapping frequency distribution curves -- Chromosomal locations of genes.
650 0 $aPharmacogenetics.
650 12 $aPharmacogenetics.
650 22 $aDrug Therapy.
650 22 $aGenetic Variation$xdrug effects.
650 22 $aGenetics, Medical.
650 7 $a44.38 pharmacology (medicine)$0(NL-LeOCL)077596536$2bcl
650 7 $a44.48 medical genetics.$0(NL-LeOCL)07761304X$2bcl
650 7 $aPharmacogenetics.$2fast$0(OCoLC)fst01060243
650 7 $aTraitement me dicamenteux.$2fmesh
650 7 $aGe ne tique me dicale.$2fmesh
650 7 $aPharmacoge ne tique.$2fmesh
650 7 $aVariation ge ne tique$xaction des me dicaments et substances chimiques.$2fmesh
650 7 $aPharmakogenetik$2gnd
650 7 $aPharmakotherapie$2gnd
650 17 $aFarmacotherapie.$2gtt
650 17 $aGenetica.$2gtt
650 17 $aGenetische variatie.$2gtt
653 0 $aDrug therapy
856 41 $3Table of contents$uhttp://catdir.loc.gov/catdir/toc/cam029/93017041.html
856 41 $3Table of contents$uhttp://www.gbv.de/dms/bs/toc/123983924.pdf
856 42 $3Publisher description$uhttp://catdir.loc.gov/catdir/description/cam025/93017041.html
938 $aBaker & Taylor$bBKTY$c220.00$d220.00$i052141296X$n0002300918$sactive
938 $aBrodart$bBROD$n45725373$c$180.00
938 $aBaker and Taylor$bBTCP$n93017041
938 $aYBP Library Services$bYANK$n463256
029 1 $aAU@$b000009957112
029 1 $aDEBBG$bBV008718131
029 1 $aDEBBG$bBV010270071
029 1 $aGBVCP$b123983924
029 1 $aHEBIS$b050099264
029 1 $aNLGGC$b106649817
029 1 $aNLM$b9305195
029 1 $aNZ1$b4471306
029 1 $aZWZ$b016782909
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 130 OTHER HOLDINGS